Cogent Biosciences
COGT
COGT
135 hedge funds and large institutions have $859M invested in Cogent Biosciences in 2022 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 53 increasing their positions, 37 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
8.57% less ownership
Funds ownership: 115.69% → 107.12% (-8.6%)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
24% less capital invested
Capital invested by funds: $1.13B → $859M (-$270M)
Holders
135
Holding in Top 10
6
Calls
$704K
Puts
$14K
Top Buyers
| 1 | +$23M | |
| 2 | +$17.1M | |
| 3 | +$12.7M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$9.86M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$6.03M |
Top Sellers
| 1 | -$20.5M | |
| 2 | -$20.3M | |
| 3 | -$15.7M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$12.7M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$6.36M |